| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3328176 | Acta Haematologica Polonica | 2012 | 5 Pages |
Abstract
ET is a relatively indolent disease, but a shorter survival of patients has been observed. Previously the main risk factors for reduced survival time were advanced age and the history of thrombotic complications. Recently the other cause of reduced survival is put on - secondary nonhematological neoplasms.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Bożena SokoÅowska, Aleksandra NowaczyÅska, Sylwia Chocholska, Ksenia Bykowska, Tomasz Gromek, Adam Walter-Croneck, Iwona Hus, Katarzyna Wejksza, Jerzy ÅwiÄ, Justyna ÅliwiÅska, Aneta Rutkowska, Elżbieta StarosÅawska, Anna DmoszyÅska,